January 18, 2021 |
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
CEPI Boosts ‘Coronavirus X’ Vaccine Search with Expanded VBI Vaccines Deal
VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
VBI Vaccines to Participate in Upcoming Investor Conferences
